Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Rakovina Therapeutics Inc. has partnered with Variational AI to research and develop new cancer treatments utilizing AI-driven drug discovery platforms. The collaboration will focus on identifying novel small-molecule therapies targeting DNA-damage response for cancer treatment, with Rakovina Therapeutics synthesizing and evaluating drug candidates at the University of British Columbia labs.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
